KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Share-based Compensation (2016 - 2026)

National Health Investors filings provide 18 years of Share-based Compensation readings, the most recent being $2.2 million for Q1 2026.

  • On a quarterly basis, Share-based Compensation fell 12.43% to $2.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $5.3 million, a 14.68% increase, with the full-year FY2025 number at $5.6 million, up 33.33% from a year prior.
  • Share-based Compensation hit $2.2 million in Q1 2026 for National Health Investors, up from $964000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $5.1 million in Q1 2022 to a low of $670000.0 in Q3 2024.
  • Median Share-based Compensation over the past 5 years was $1.0 million (2022), compared with a mean of $1.5 million.
  • Biggest five-year swings in Share-based Compensation: crashed 58.59% in 2023 and later soared 55.9% in 2025.
  • National Health Investors' Share-based Compensation stood at $1.0 million in 2022, then decreased by 16.59% to $865000.0 in 2023, then fell by 22.54% to $670000.0 in 2024, then soared by 43.88% to $964000.0 in 2025, then surged by 132.37% to $2.2 million in 2026.
  • The last three reported values for Share-based Compensation were $2.2 million (Q1 2026), $964000.0 (Q4 2025), and $983000.0 (Q3 2025) per Business Quant data.